Go to
Healthcare
Go to
- Cleantech
- Communications Cloud & Infrastructure
- Consumer & Cannabis
- Cryptoasset & Blockchain
- Disruptive Industrial Tech
- E-Commerce
- Financial Technology & Information Services
- Healthcare
- Infrastructure Software & Cybersecurity
- Internet & Digital Media
- Semiconductors
- Semiconductor Equipment
- Software & Services
Needham’s healthcare practice covers a wide breadth of subsectors within biotechnology, biopharmaceuticals, medical technology, diagnostics, and techbio, including AI drug discovery. Therapeutic indications of focus include, but are not limited to: autoimmune, cardiovascular, dermatology, fibrosis, gastrointestinal, hematology, infectious, inflammation & immunology, metabolic, neuroscience, oncology, ophthalmology, orphan, pain, pulmonary and renal diseases. Modalities of focus include, but are not limited to: small molecules, biologics, ADCs, ASOs, cell therapies, gene therapies, peptides, protein degraders, radiopharmaceuticals, RNA, and vaccines.
Recent Transactions
Oct 2026
$575M
Convertible
Lead Manager
Aug 2026
$40M
Follow-On Offering
Co-Manager
May 2026
$150M
Registered Direct Offering
Lead Manager
May 2026
$300M
Registered Direct Offering
Lead Manager
May 2026
$805M
Follow-On Offering
Co-Manager
May 2026
$150M
Follow-On Offering
Lead Manager